FDA Inspection 977281 — Wake Forest Institute For Regenerative Medicine
The FDA completed an inspection of Wake Forest Institute For Regenerative Medicine on Jul 20, 2016 in Winston Salem, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 20, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Winston Salem, NC (United States)